data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Ensysce Biosciences
(NASDAQ:ENSC)
$0.569
-0.2994[-34.48%]
At close: Jul 1
$0.5558
-0.0132[-2.32%]
After Hours: 7:59PM EDT
Day High/Low0.56 - 0.68
52 Week High/Low0.4 - 17.12
Open / Close0.67 / 0.57
Float / Outstanding16.6M / 34.6M
Vol / Avg.3.8M / 1.6M
Mkt Cap19.7M
P/E-
50d Avg. Price0.66
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float16.6M

Ensysce Biosciences (NASDAQ:ENSC), Quotes and News Summary

Ensysce Biosciences (NASDAQ: ENSC)

Day High/Low0.56 - 0.68
52 Week High/Low0.4 - 17.12
Open / Close0.67 / 0.57
Float / Outstanding16.6M / 34.6M
Vol / Avg.3.8M / 1.6M
Mkt Cap19.7M
P/E-
50d Avg. Price0.66
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float16.6M
Benzinga - 1 day ago
Benzinga - May 23, 2022, 4:17PM
Benzinga - May 17, 2022, 12:51PM
Benzinga - May 17, 2022, 12:02PM
Benzinga - May 12, 2022, 4:43PM
Benzinga - May 5, 2022, 9:16AM
Benzinga - Apr 18, 2022, 4:10PM
Benzinga - Apr 6, 2022, 1:15PM
Benzinga - Apr 6, 2022, 1:01PM
Benzinga - Mar 31, 2022, 4:19PM
Benzinga - Mar 1, 2022, 10:05AM
Benzinga - Mar 1, 2022, 10:04AM
load more
Sector: Health Care.Industry: Biotechnology
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.060
REV603.098K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ensysce Biosciences Questions & Answers

Q
How do I buy Ensysce Biosciences (ENSC) stock?
A

You can purchase shares of Ensysce Biosciences (NASDAQ: ENSC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ensysce Biosciences's (ENSC) competitors?
Q
What is the target price for Ensysce Biosciences (ENSC) stock?
A

The latest price target for Ensysce Biosciences (NASDAQ: ENSC) was reported by Lake Street on Tuesday, November 30, 2021. The analyst firm set a price target for 4.00 expecting ENSC to rise to within 12 months (a possible 602.99% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ensysce Biosciences (ENSC)?
A

The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $0.569 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Ensysce Biosciences (ENSC) pay a dividend?
A

There are no upcoming dividends for Ensysce Biosciences.

Q
When is Ensysce Biosciences (NASDAQ:ENSC) reporting earnings?
A

Ensysce Biosciences’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Ensysce Biosciences (ENSC) going to split?
A

There is no upcoming split for Ensysce Biosciences.

Q
What sector and industry does Ensysce Biosciences (ENSC) operate in?
A

Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.